“In Vitro Diagnostic Testing Services reaches 12 billion tests per year. Genomic technology and China healthcare expansion driving global growth.....”
Report Overview: A market that just keeps on growing. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially genomics. Learn all about it in this new report from Howe Sound Research. A range of dynamic trends are pushing market growth and company valuations.
Trends like ...... - changing demographics - emerging economies and global prosperity - biotechnology advances in genetics - healthcare expansion in China - climate change - globalization - automation
Exciting technical developments especially in the area of molecular diagnostics and pharmacogenomics hold the promise of a dynamic, growing and evolving world market that is moving out of the national and regional orientation and onto a global stage.
“In Vitro Diagnostic Testing Services including Cardiac, Molecular Diagnostic and Genomic. Strategies & Trends. Price & Volume Forecasts by Laboratory Department. 2017 to 2022 - Global Version" provides data that analysts and planners can use. Hundreds of pages of information including a complete list of Current 2017 United States Medicare Fee Payment Schedules to help sharpen your pricing. Make facilities planning decisions. Forecast demand for new testing regimes or technologies. Make research investment decisions.
Order an Enterprise Version specifically customized for your organizations needs for distribution throughout your company.
Based on extensive primary and secondary research the testing volume data is broken down into price and volumes allowing researchers and investors to quickly create informed and reasonable forecasts of demand. Assistance in providing specific growth and market size estimates for new technology tests is normally provided without additional charges. Existing laboratories and hospitals can use the information directly to forecast and plan for clinical facilities growth. Again, assistance in using the information is normally provided without additional charges.
The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report. All report data is available in Excel format on request. Make investment decisions and valuations with confidence using the latest data.
Our reports have been used by over 10K customers, including:
The global point of care diagnostrics market size is projected to reach USD 50.6 billion by 2025 from USD 29.5 billion in 2020, at a CAGR of 11.4%. Factors such as the technological advancements in point of care devices in the market are propelling the growth of the market. Additionally, rising cases of investments from both private and public...
The nucleic acid amplification, detection, and diagnostics market was valued at US$ 14,014.59 million in 2019 and is projected to reach US$ 38,162.68 million by 2027; it is expected to grow at a CAGR of 13.4% during 2020–2027. The growth of the nucleic acid amplification, detection, and diagnostics market is mainly attributed to the factors...
The women’s health diagnostics market is projected to reach USD 36.6 billion by 2025 from USD 25.0 billion in 2020, at a CAGR of 7.9% during the forecast period. In the past decade, the demand for various health diagnostic tests has increased significantly across the globe. Currently, the market is mainly driven by growing awareness about...
The global irritable bowel syndrome (IBS) diagnostics market is expected to reach US$ 3,880.91 million by 2028 from US$ 2,470.61 million in 2020; it is estimated to grow at a CAGR of 5.9% from 2020 to 2028. Increasing prevalence of irritable bowel syndrome and associated conditions and increasing number of FDA approvals and diagnostics...
India In-vitro diagnostics market estimated to be valued at USD USD 1255.18 million in 2020 and is expected to reach approximately USD 1990.99 million in 2026, registering a CAGR of nearly 7.10% during the forecast period. In the context of COVID-19, government organizations in various countries, research institutes, and many global...
The global chromatography instruments market is projected to reach USD 11.0 billion by 2025 from USD 8.6 billion in 2020 at a CAGR of 5.1%. Growth in the chromatography instruments market can be attributed to increasing investments by pharma and biotech companies in R&D activities, growing demand for hyphenated chromatography techniques, and...
The major factors responsible for the growth of the mammography market include the growing prevalence of breast cancer, technological advancements in the field of breast imaging, and investment from various organizations in breast cancer screening campaigns. - According to the Centers for Disease Control and Prevention (CDC) reports,...
The chiral chromatography columnmarketsize is projected to reach USD 123 million by 2025 from an estimated USD 99 million in 2020, at a CAGR of4.5% during the forecast period. Increasing R&D investments in the pharmaceutical and biotechnology industry is creating demand opportunities for the chiral chromatography column industry. Also,increasing...
Inborn Gene or Chromosome Alterations Tests - Medical Devices Pipeline Assessment, 2020
Medical Devices sector report, “Inborn Gene or Chromosome Alterations Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Inborn Gene or Chromosome Alterations...
Summary Biocartis Group NV (Biocartis) operates as a molecular diagnostics company that provides personalized medicine for patients through its molecular diagnostics.The company undertakes the development of diagnostics technology platforms for multiplexed detection of bio-analytes, with oncology as its key focus area. Its...
Medical Devices Sales
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.